Pouchitis in a rat model of ileal J pouch-anal anastomosis

Inflammatory Bowel Diseases

Volumn 8, Issue 1, 2002, Pages 23-34

  Shebani, Khaled O ^a   Stucchi, Arthur F ^a   Fruin, Brent ^a   McClung, James P ^a   Gee, Denise ^a   Beer, Eve R ^a   LaMorte, Wayne W ^a   Becker, James M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ileal pouch anal anastomosis; Pouchitis; Rat model

Indexed keywords

DEXTRAN SULFATE; ISOPROSTANE; MYELOPEROXIDASE;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL OVERGROWTH; BRUCELLA; CLINICAL FEATURE; COLON RESECTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE EXACERBATION; ILEITIS; ILEOANAL ANASTOMOSIS; INTESTINE RADIOGRAPHY; INTESTINE TRANSIT TIME; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; RECTUM RESECTION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; ULCERATIVE COLITIS; URINE LEVEL; WEIGHT GAIN;

EID: 0036163999     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200201000-00004     Document Type: Article

References (54)

1. Restorative protocolectomy with ileal reservoir: Indications and results
2. Limited influence of pouch function on quality of life after ileal pouch-anal anastomosis
3. What is the better surgical technique in ileal-pouch-anal anastomosis? Mucosectomy
4. Surgical therapy for ulcerative colitis and Crohn's disease
5. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis
6. Ileoanal pouch operation: Long-term outcome with or without diverting ileostomy
7. Pouchitis-aetiology, pathogenesis, therapy
8. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis
9. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors
10. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses
11. Pouchitis: Definition and pathogenesis
12. The Kock continent ileostomy
13. Pouchitis in the Kock continent ileostomy and the ileoanal pouch
14. Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment
15. How do you treat refractory pouchitis and when do you decide to remove the pouch?
16. Medical therapy for induction and maintenance of remission in pouchitis: A systematic review
17. Ileal pouch salvage following failed ileal pouch-anal anastomosis
18. Impaired absorption of cholesterol and bile acids in patients with an ileoanal anastomosis
19. Quantitative assessment of pelvic ileal reservoir emptying with a semisolid radionuclide enema. A correlation with clinical outcome
20. Mucosal blood flow following restorative proctocolectomy: Pouchitis is associated with mucosal ischaemia
21. Morphology, mucin histochemistry and crypt cell kinetics of ileal mucosa in an experimental model
22. An assessment of the risk of neoplasia in long-term ileal reservoirs using the DMH rodent model
23. A rat model of ileal pouch-rectal anastomosis
24. Dextran sulfate sodium (DSS) in rats. Clinical, structural, and ultrastructural aspects
25. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats
26. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
27. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification
28. Role of stasis and oxidative stress in ileal pouch inflammation
29. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo
30. The role of the intestinal microflora in experimental colitis
31. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease
32. Prospective study of morphologic and functional changes with time in the mucosa of the ileoanal pouch-functional appraisal using transmucosal potential differences
33. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats
34. Anatomic features and radiographic observations of gastric emptying and small intestinal motility in the rat
35. Solubility and intestinal transit time limit calcium absorption in rats
36. Pouchitis: Result of microbial imbalance
37. Acute pouchitis and deficiencies of fuel
38. Pouchitis: Pathophysiology and treatment
39. Ileal pouch dialysate is cytotoxic to epithelial cell lines, but not to CaCo-2 monolayers
40. Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: Their association with inflammatory change and faecal stasis
41. Ileal pouches: Adaptation and inflammation
42. Intestinal permeability in the ileal pouch
43. Effects of intestinal stasis on intercellular adhesion molecule 1 expression in the rat: Role of enteric bacteria
44. Enteric microflora in IBD: Pathogens or commensals?
45. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites
46. Depleted mucosal antioxidant defences in inflammatory bowel disease
47. The role of reactive oxygen metabolites in ulcerative colitis
48. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease
49. Role of oxygen free radicals in the etiology of pouchitis
50. Evidence for oxidative stress in the etiology of pouchitis
51. Pathogenesis of tissue injury: Role of reactive metabolites of oxygen and nitrogen
52. Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats
53. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
54. Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents